Intrapericardial botulinum toxin treatment for bradycardia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 20, 2005
Grant Date -
N/A
app pub date -
Aug 10, 1999
filing date -
Aug 10, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods for treating cardiac muscle disorders, such as cardiac arrhythmias, by administration of a neurotoxin to cardiac muscle are disclosed. Bradycardia can be alleviated for several months by a single intrapericardial or intracardiac injection or infusion of a botulinum toxin. Tachycardia can be alleviated by preganglionic sympathetic nervous system administration of a botulinum toxin.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully